"Is Underutilization of Adjuvant Therapy in Resected Non-small Cell Lung Cancer Associated with Socioeconomic Disparities?".
Although adjuvant systemic therapy (AT) has demonstrated improved survival in patients with resected non-small cell lung cancer, it remains underutilized. Recent trials demonstrating improve...